LUPINPharmaceuticals
Lupin Ltd — PE Ratio & Valuation Analysis
₹2313.90
-0.66%
Current P/E22.00xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E75.4x70.8% below avg
✅
30.8% Discount to Industry
LUPIN P/E 22.00x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹71.69 | ₹2110 | 29.4x |
| 2024 | ₹41.87 | ₹2356 | 56.3x |
| 2023 | ₹9.41 | ₹1323 | 140.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Lupin Ltd Valuation
Lupin Ltd (LUPIN) currently trades at 22.00x earnings. The Pharmaceuticals sector average PE is 31.77x. LUPIN is trading at a discount to peers — may indicate relative value. Historically, LUPIN has traded at an average PE of 75.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
20.62%
Dividend Yield
0.58%
More on Lupin Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.